CVS Congressional Stock Trades
CVS HEALTH CORP CMN
Last disclosed trade Jun 2
Every disclosed trade in CVS by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Coldpine’s read
Hill's seat on Financial Services gives him oversight relevance to insurers and pharmacy-benefit managers like CVS. The 4-day disclosure lag is unusually fast, making this sale recent and potentially actionable. At least one other member sold CVS in the same direction within 30 days, suggesting modest cluster behavior around the name.
James French Hill · Sold · Jan 31
Coldpine scores and writes a rationale for every congressional trade. See the full scored analysis with Pro →
Follow $CVS
Get notified when any member of Congress trades $CVS. Free, no card, no spam.
Members who trade CVS
Recent disclosed trades in CVS
| Date | Member | Type | Amount |
|---|---|---|---|
| Jun 2 | Rohit Khanna(CA) | buy | $1K–$15K |
| Apr 13 | Rohit Khanna(CA) | buy | $1K–$15K |
| Feb 20 | Michael T. McCaul(TX) | buy | $15K–$50K |
| Jan 29 | John Boozman(AR) | buy | $1K–$15K |
| Jan 13 | Michael T. McCaul(TX) | sell | $15K–$50K |
| Nov 21 | Dwight Evans(PA) | sell | $1K–$15K |
| Nov 21 | Dwight Evans(PA) | sell | $1K–$15K |
| Oct 27 | Michael T. McCaul(TX) | sell | $15K–$50K |
| Aug 22 | Michael T. McCaul(TX) | sell | $50K–$100K |
| Aug 8 | Adam Smith(WA) | sell | $1K–$15K |
| Aug 4 | Rohit Khanna(CA) | buy | $1K–$15K |
| May 28 | Rohit Khanna(CA) | buy | $1K–$15K |
| May 19 | Rohit Khanna(CA) | buy | $1K–$15K |
| May 15 | Rob Bresnahan(PA) | sell | $1K–$15K |
| Apr 10 | Michael T. McCaul(TX) | sell | $100K–$250K |
| Mar 12 | Rohit Khanna(CA) | buy | $1K–$15K |
| Mar 6 | Rohit Khanna(CA) | buy | $1K–$15K |
| Jan 31 | James French Hill(AR) | sell | $15K–$50K |
| Jan 22 | Rohit Khanna(CA) | buy | $1K–$15K |
| Jan 17 | Rohit Khanna(CA) | buy | $1K–$15K |
Showing 20 of 67 disclosed trades.
Sign up free for the full history, signal scores, and price-vs-trades chart. Pro adds Coldpine's read — the AI narrative on each trade.
Create a free accountData sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores — free with an account →